Edition:
United Kingdom

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

15.18CNY
23 Feb 2018
Change (% chg)

¥-0.12 (-0.78%)
Prev Close
¥15.30
Open
¥15.35
Day's High
¥15.38
Day's Low
¥15.12
Volume
10,853,717
Avg. Vol
12,450,906
52-wk High
¥21.50
52-wk Low
¥14.53

Select another date:

Mon, Jan 29 2018

BRIEF-Humanwell Healthcare Expects 2017 Net Profit To Rise 108-114 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 108-114 PERCENT Y/Y VERSUS 832 MILLION YUAN ($131.56 million) YEAR AGO Source text in Chinese: http://bit.ly/2DIIsBj Further company coverage: ($1 = 6.3242 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Humanwell Healthcare Group sells bio-pharma firm for 350 mln yuan

* Says it sold 100 percent stake in Yichang-based bio-pharma firm for 350 million yuan

BRIEF-Humanwell Healthcare's Unit To Boost Capital Of Lifestyles Healthcare

* SAYS UNIT SIGNS AGREEMENT TO BOOST CAPITAL OF LIFESTYLES HEALTHCARE PTE WITH HEALTH PRODUCTS FIRM'S 59 PERCENT STAKE WORTH $131.1 MILLION Source text in Chinese: http://bit.ly/2kK6weL Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Humanwell Healthcare Group completes investment in unit RFSW Investment Pte Ltd

* Says it invested 805.4 million yuan in wholly owned Singapore unit RFSW Investment Pte. Ltd

BRIEF-Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets

* Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic

BRIEF-Humanwell Healthcare's shareholder bought shares worth 143.7 mln yuan during Jun 28-Nov 29

* SAYS CONTROLLING SHAREHOLDER HAS BOUGHT 143.7 MILLION YUAN ($21.78 million) WORTH OF COMPANY SHARES BETWEEN JUNE 28 AND NOV 29 Source text in Chinese: http://bit.ly/2k9Y2AT Further company coverage: ($1 = 6.5966 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Humanwell Healthcare Group unit passes FDA approval

* Says its 75 percent-owned unit received approval for its soft capsule named Dutasteride Capsule from U.S Food and Drug Administration

BRIEF-Humanwell Healthcare Group receives subsidy

* Says it received subsidy of 35 million yuan from government, on Nov. 15

BRIEF-Humanwell Healthcare and unit to increase stake in Tianfeng Securities

* Says it and unit plan to acquire additional 2.18 percent stake in Tianfeng Securities for 305.1 million yuan ($45.97 million)

BRIEF-Humanwell Healthcare's 9-month net profit up 211.3 pct y/y

Oct 30 Humanwell Healthcare Group Co Ltd * Says 9-month net profit up 211.3 percent y/y Source text in Chinese: http://bit.ly/2gV5KgU Further company coverage: (Reporting by Hong Kong newsroom)

Select another date: